Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 2
1967 4
1968 2
1969 3
1970 5
1972 1
1973 1
1974 5
1975 2
1976 3
1978 2
1979 3
1980 2
1981 5
1982 5
1983 5
1984 10
1985 7
1986 6
1987 7
1988 7
1989 8
1990 3
1991 8
1992 3
1993 2
1994 9
1995 10
1996 10
1997 11
1998 10
1999 9
2000 4
2001 4
2002 10
2003 5
2004 7
2005 9
2006 5
2007 10
2008 13
2009 15
2010 10
2011 9
2012 14
2013 7
2014 16
2015 19
2016 13
2017 13
2018 12
2019 11
2020 12
2021 10
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

374 results
Results by year
Filters applied: . Clear all
Page 1
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505.
Kitagawa R, Katsumata N, Shibata T, Kamura T, Kasamatsu T, Nakanishi T, Nishimura S, Ushijima K, Takano M, Satoh T, Yoshikawa H. Kitagawa R, et al. Among authors: kasamatsu t. J Clin Oncol. 2015 Jul 1;33(19):2129-35. doi: 10.1200/JCO.2014.58.4391. Epub 2015 Mar 2. J Clin Oncol. 2015. PMID: 25732161 Clinical Trial.
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial.
Onda T, Satoh T, Ogawa G, Saito T, Kasamatsu T, Nakanishi T, Mizutani T, Takehara K, Okamoto A, Ushijima K, Kobayashi H, Kawana K, Yokota H, Takano M, Kanao H, Watanabe Y, Yamamoto K, Yaegashi N, Kamura T, Yoshikawa H; Japan Clinical Oncology Group. Onda T, et al. Among authors: kasamatsu t. Eur J Cancer. 2020 May;130:114-125. doi: 10.1016/j.ejca.2020.02.020. Epub 2020 Mar 13. Eur J Cancer. 2020. PMID: 32179446 Clinical Trial.
IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma.
Kasamatsu T, Hashimoto N, Sakaya N, Awata-Shiraiwa M, Ishihara R, Murakami Y, Masuda Y, Gotoh N, Nagai K, Oda T, Yokohama A, Saitoh T, Handa H, Tsukamoto N, Hayashi K, Murakami H. Kasamatsu T, et al. Clin Exp Med. 2021 May;21(2):323-329. doi: 10.1007/s10238-020-00681-w. Epub 2021 Mar 12. Clin Exp Med. 2021. PMID: 33709342
[Brachytherapy for prostate cancer].
Yorozu A, Toya K, Ohashi T, Ohsuga K, Ito R, Kasamatsu T, Saito S, Momma T. Yorozu A, et al. Among authors: kasamatsu t. Gan To Kagaku Ryoho. 2006 Apr;33(4):424-7. Gan To Kagaku Ryoho. 2006. PMID: 16612148 Review. Japanese.
PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes.
Gotoh N, Minato Y, Saitoh T, Takahashi N, Kasamatsu T, Souma K, Oda T, Hoshino T, Sakura T, Ishizaki T, Shimizu H, Takizawa M, Yokohama A, Tsukamoto N, Handa H, Murakami H. Gotoh N, et al. Among authors: kasamatsu t. Eur J Haematol. 2020 Jun;104(6):526-537. doi: 10.1111/ejh.13393. Epub 2020 Mar 4. Eur J Haematol. 2020. PMID: 32003046
Minimization of curative surgery for treatment of early cervical cancer: a review.
Arimoto T, Kawana K, Adachi K, Ikeda Y, Nagasaka K, Tsuruga T, Yamashita A, Oda K, Ishikawa M, Kasamatsu T, Onda T, Konishi I, Yoshikawa H, Yaegashi N; Gynecologic Cancer Study Group of the Japan Clinical Oncology Group. Arimoto T, et al. Among authors: kasamatsu t. Jpn J Clin Oncol. 2015 Jul;45(7):611-6. doi: 10.1093/jjco/hyv048. Epub 2015 Apr 16. Jpn J Clin Oncol. 2015. PMID: 25888708 Review.
Athletic Trainers' Practice Patterns Regarding Medical Documentation.
Eberman LE, Neil ER, Nottingham SL, Kasamatsu TM, Bacon CEW. Eberman LE, et al. Among authors: kasamatsu tm. J Athl Train. 2019 Jul;54(7):822-830. doi: 10.4085/1062-6050-230-18. Epub 2019 Aug 6. J Athl Train. 2019. PMID: 31386576 Free PMC article.
374 results